Home/Pipeline/HSK21542

HSK21542

Pruritus (Chronic Liver Disease)

Phase IIIActive

Key Facts

Indication
Pruritus (Chronic Liver Disease)
Phase
Phase III
Status
Active
Company

About Haisco Pharmaceutical Group

Haisco Pharmaceutical Group's mission is to develop and deliver innovative, high-quality medicines to address unmet medical needs in China and globally. The company has achieved significant scale, becoming one of China's top pharmaceutical firms by market value, through a successful 'generic-to-innovative' transition strategy. Its core strategy is built on vertical integration, using stable cash flows from its generics and established drug portfolio to fund R&D in high-growth therapeutic areas, while expanding its commercial reach across China's vast healthcare market.

View full company profile